Uniphar (LON:UPR) Sets New 52-Week High – Here’s What Happened

Uniphar plc (LON:UPR)’s share price reached a new 52-week high on Wednesday . The company traded as high as GBX 240 ($3.20) and last traded at GBX 237 ($3.16), with a volume of 39509 shares. The stock had previously closed at GBX 235 ($3.13).

Analysts Set New Price Targets

Separately, Shore Capital reiterated a “buy” rating on shares of Uniphar in a report on Tuesday, February 25th.

Uniphar Trading Down 1.7 %

The company’s 50-day simple moving average is GBX 222.99 and its 200 day simple moving average is GBX 198.31. The firm has a market capitalization of £715.95 million, a PE ratio of 15.99 and a beta of 0.75. The company has a quick ratio of 0.60, a current ratio of 0.90 and a debt-to-equity ratio of 119.48.

Uniphar Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 16th. Investors of record on Thursday, April 24th will be issued a dividend of €0.01 ($0.01) per share. This represents a yield of 0.47%. This is a boost from Uniphar’s previous dividend of $0.01. The ex-dividend date is Thursday, April 24th. Uniphar’s dividend payout ratio (DPR) is 13.91%.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.